SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending following its preliminary Q3 revenue exceeding expectations, sparking a surge of investor enthusiasm. The community is actively discussing the company's substantial year-over-year growth and its reinforced position as a crucial 'picks and shovels' provider for the expanding AI data center infrastructure.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is experiencing an intense sell-off and community debate following the abrupt departures of its CFO and general counsel amid an ongoing accounting review, delayed regulatory filings, and reduced financial guidance. While many see the over 50% plunge as an extreme overreaction and a potential buying opportunity, others express deep concern over financial irregularities, referencing a past short report, and caution against further downside.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is drawing significant attention for its expanding multi-chain utility and growing daily fee revenue, with the community actively speculating on an imminent price breakout to "drop a zero" as it sees aggressive buying. Despite this bullish sentiment and new exchange listings, a segment of the community cautions that it may be a pump and dump.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Satellos Bioscience (MSLE) is trending following its recent NASDAQ listing and a significant $50 million financing, sparking intense debate around its novel Duchenne Muscular Dystrophy drug, SAT-3247. The community is split between those hailing its "revolutionary" muscle regeneration potential and acquisition prospects, and skeptics citing its early-stage data and concerns over dilution.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is trending after reporting strong earnings that exceeded profit expectations and showed significant revenue growth, alongside a new healthcare customer deal. The community is actively discussing its sharp recovery after a volatile period marked by a secondary offering and a major analyst downgrade, emphasizing its long-term potential in AI robotics and warehouse automation despite ongoing valuation concerns.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display Technologies, Specialty Materials, Environmental Technologies, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computer, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Environmental Technologies segment focuses on manufacturing ceramic substrates and filter products for emissions control in mobile applications. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning (GLW) is trending after a significant agreement with Meta Platforms to supply fiber optics for AI data centers, firmly establishing its role as a critical infrastructure provider. The community is actively discussing its potential as a long-term wealth builder, driven by its diverse portfolio supporting the AI buildout and its continued ascent to new highs.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Investors are heavily anticipating Upstart's upcoming earnings report, with community sentiment sharply divided between hopes for a rebound based on its AI lending technology and deep concerns over recent sector underperformance and management's perceived lack of shareholder focus.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

Caesars Entertainment is trending after recent earnings revealed widening losses and declining Las Vegas revenue, amplifying community concerns over its substantial debt and the broader impact of rising fees and online prediction markets on the traditional gaming sector. Investors are divided on whether the stock is a deep value opportunity or poised for continued challenges amidst these competitive and financial pressures.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors react to the inauguration of its Eagle Line pilot production facility, signaling a crucial step towards scalable solid-state battery manufacturing. The community is actively debating whether this progress, including observed OEM presence, translates to imminent commercialization and new partnerships, or if skepticism over revenue and formal customer announcements will persist ahead of upcoming earnings.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is actively discussed amid a broader SaaS sector sell-off fueled by concerns over AI disruption, a sentiment amplified by recent mixed earnings interpretations and a leadership change focused on AI transformation. However, a substantial investment from an activist hedge fund and a new share buyback program are signaling market confidence in Workday's strategic pivot to an AI-driven future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Research Analysts Offer Predictions for NRIX Q1 Earnings

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) - Investment analysts at HC Wainwright raised their Q1 2026 earnings per share estimates for Nurix Therapeutics in a report released on Thursday...

Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) CFO Sells 3,661 Shares of Stock

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Houte Hans Van sold 3,661 shares of the business's stock in a transaction dated Friday, January 30th. The shares were sold at an average...

Houte Hans Van Sells 3,661 Shares of Nurix Therapeutics (NASDAQ:NRIX) Stock

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Houte Hans Van sold 3,661 shares of the stock in a transaction that occurred on Friday, January 30th. The shares were sold at an average...

Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 4,895 Shares

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) insider Gwenn Hansen sold 4,895 shares of the company's stock in a transaction dated Friday, January 30th. The shares were sold at an average...

Royal Bank Of Canada Issues Positive Forecast for Nurix Therapeutics (NASDAQ:NRIX) Stock Price

Royal Bank Of Canada boosted their target price on shares of Nurix Therapeutics from $28.00 to $30.00 and gave the stock an "outperform" rating in a report on Thursday...

Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Misses Revenue Estimates

Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of +2.88% and -24.12%, respectively, for the quarter ended November 2025. Do the numbers hold clues to what lies ahead for the stock?

Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 6.7% - Time to Sell?

Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 6.7% - What's Next...

Nurix Therapeutics (NASDAQ:NRIX) Posts Earnings Results, Beats Expectations By $0.04 EPS

Nurix Therapeutics (NASDAQ:NRIX - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.82) earnings per share (EPS) for the quarter, beating the consensus estimate of...

Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eighteen ratings firms that are presently covering the firm...

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.77	--	--	N/A
Q4 '25	-$0.87	-$0.82	5.85%	BEAT
Q3 '25	-$0.82	-$1.03	-26.01%	MISSED
Q2 '25	-$0.70	-$0.52	25.76%	BEAT
Q1 '25	-$0.76	-$0.67	12.06%	BEAT

NRIX
Nurix Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest NRIX News

NRIXNurix Therapeutics Inc